Study Number: VIS410-203—A Phase 2b, multi-center, randomized, double-blind, controlled study to evaluate the efficacy and safety of intravenous VIS410 in addition to Oseltamivir (Tamiflu) compared with Oseltamivir alone in hospitalized adults with infulenza A infection requiring oxygen support.
Principal Investigator(s): Stephen Ryan, MD
Study Coordinator: Jami Smith, [email protected], 253-403-0389
Study Number: 018CTXX15001—An observational, multi-center study of the prevalence of Cerebrotendinous Xanthomatosis (CTX) in patient populations diagnosed with early onset Idiopathic Bilateral Cataracts.
Study Number: CTBM100C2407—A prospective observational study in cystic fibrosis patients with chronic respiratory pseudomonas aeruginosa infection treated with TOBI Podhaler (tobramycin inhalation powder) or other FDA approved inhaler antipseudomonal antibacterial drugs.